Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

被引：0

作者：

Maribel Forero-Castro

Cristina Robledo

Rocío Benito

Irene Bodega-Mayor

Inmaculada Rapado

María Hernández-Sánchez

María Abáigar

Jesús Maria Hernández-Sánchez

Miguel Quijada-Álamo

José María Sánchez-Pina

Mónica Sala-Valdés

Fernanda Araujo-Silva

Alexander Kohlmann

José Luis Fuster

Maryam Arefi

Natalia de las Heras

Susana Riesco

Juan N Rodríguez

Lourdes Hermosín

Jordi Ribera

Mireia Camos Guijosa

Manuel Ramírez

Cristina Díaz de Heredia Rubio

Eva Barragán

Joaquín Martínez

José M Ribera

Elena Fernández-Ruiz

Jesús-María Hernández-Rivas

机构：

[1] IBSAL,Department of Hematology

[2] IBMCC,Department of Pediatric Oncohematology

[3] University of Salamanca,Department of Hematology

[4] CSIC,Department of Hematology

[5] Cancer Research Center,Department of Pediatrics

[6] Campus Miguel de Unamuno,Department of Hematology

[7] School of Biological Sciences (GICBUPTC research group),Department of Hematology

[8] Universidad Pedagógica y Tecnológica de Colombia (UPTC),Department of Hematology

[9] Avenida Central del Norte 39-115,Department of Hematology

[10] Molecular Biology Unit,undefined

[11] Hospital Universitario de La Princesa,undefined

[12] Instituto de Investigación Sanitaria Princesa (IIS-IP),undefined

[13] Calle Diego de León,undefined

[14] 62,undefined

[15] Hospital 12 de Octubre,undefined

[16] Avenida de Córdoba s/n,undefined

[17] Personalised Healthcare and Biomarkers,undefined

[18] Innovative Medicines and Early Development Biotech Unit,undefined

[19] AstraZeneca,undefined

[20] Hospital Universitario Virgen de la Arrixaca,undefined

[21] Ctra. Madrid-Cartagena,undefined

[22] s/n,undefined

[23] Hospital Río Carrión,undefined

[24] Av. Donantes de Sangre,undefined

[25] s/n,undefined

[26] Hospital Virgen Blanca,undefined

[27] Altos de Nava s/n,undefined

[28] Hospital Universitario de Salamanca,undefined

[29] Paseo de San Vicente,undefined

[30] 88-182,undefined

[31] Hospital Juan Ramón Jiménez,undefined

[32] Ronda Exterior Norte,undefined

[33] s/n,undefined

[34] Hospital de Jerez,undefined

[35] Carr Madrid-Cádiz,undefined

[36] ICO-Hospital Germans Trias i Pujol,undefined

[37] Instituto de Investigación Josep Carreras,undefined

[38] (Can Ruti),undefined

[39] Carretera de Canyet,undefined

[40] s/n,undefined

[41] Hematology Laboratory,undefined

[42] Institut de Recerca Pediátrica Hospital Sant Joan de Déu de Barcelona,undefined

[43] Passeig de Sant Joan de Déu,undefined

[44] 2,undefined

[45] Pediatric Oncohematology,undefined

[46] Hospital Universitario Infantil Niño Jesús,undefined

[47] Instituto de Investigación Sanitaria Princesa (IIS-IP),undefined

[48] Pediatric Oncohematology,undefined

[49] Hospital Vall d’Hebron,undefined

[50] Passeig de la Vall d'Hebron,undefined

来源：

British Journal of Cancer | 2017年 / 117卷

关键词：

acute lymphoblastic leukaemia (ALL); next-generation sequencing (NGS); prognosis; outcome; survival; mutation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：256 / 265

页数：9

共 50 条

[1] Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
Forero-Castro, Maribel
Robledo, Cristina
Benito, Rocio
Bodega-Mayor, Irene
Rapado, Inmaculada
Hernandez-Sanchez, Maria
Abaigar, Maria
Maria Hernandez-Sanchez, Jesus
Quijada-Alamo, Miguel
Maria Sanchez-Pina, Jose
Sala-Valdes, Monica
Araujo-Silva, Fernanda
Kohlmann, Alexander
Luis Fuster, Jose
Arefi, Maryam
de las Heras, Natalia
Riesco, Susana
Rodriguez, Juan N.
Hermosin, Lourdes
Ribera, Jordi
Camos Guijosa, Mireia
Ramirez, Manuel
de Heredia Rubio, Cristina Diaz
Barragan, Eva
Martinez, Joaquin
Ribera, Jose M.
Fernandez-Ruiz, Elena
Hernandez-Rivas, Jesus-Maria
BRITISH JOURNAL OF CANCER, 2017, 117 (02) : 256 - 265
[2] MUTATIONS IN TP53 AND JAK2 GENES ARE ASSOCIATED WITH POOR PROGNOSIS IN PEDIATRIC AND ADULT PATIENTS WITH B-CELL PRECURSOR ALL
Forero-Castro, M.
Robledo, C.
Benito, R.
Abaigar, M.
Hernandez-Sanchez, M.
Hernandez-Sanchez, J. M.
Quijada-Alamo, M.
Fuster, J. L.
Arefi, M.
de las Heras, N.
Rodriguez, J. N.
Hermosin, L.
Ribera, J.
Bodega Mayor, I.
Rapado, I.
Sanchez-Pina, J. M.
Camos Guijosa, M.
Ramirez-Orellana, M.
de Heredia Rubio, C. Diaz
Barragan, E.
Martinez, J.
Fernandez-Ruiz, E.
Ribera, J. M.
Hernandez-Rivas, J. M.
HAEMATOLOGICA, 2016, 101 : 200 - 200
[3] Characteristics of TP53 mutation in adult precursor B-cell acute lymphoblastic leukemia
Samy, Heba
Fouad, Dina A.
Ali, Basma S. M.
Attia, Hend
EGYPTIAN JOURNAL OF HAEMATOLOGY, 2023, 48 (01): : 13 - 18
[4] JAK2 Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia
Steeghs, Elisabeth M. P.
Jerchel, Isabel S.
de Goffau-Nobel, Willemieke
Hoogkamer, Alex Q.
Boer, Judith M.
Boeree, Aurelie
van de Ven, Cesca
Koudijs, Marco J.
Besselink, Nicolle J. M.
de Groot-Kruseman, Hester A.
Zwaan, C. Michel
Horstmann, Martin A.
Pieters, Rob
Den Boer, Monique L.
BLOOD, 2016, 128 (22)
[5] JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia
Steeghs, Elisabeth M. P.
Jerchel, Isabel S.
de Goffau-Nobel, Willemieke
Hoogkamer, Alex Q.
Boer, Judith M.
Boeree, Aurelie
van de Ven, Cesca
Koudijs, Marco J.
Besselink, Nicolle J. M.
de Groot-Kruseman, Hester A.
Zwaan, Christian Michel
Horstmann, Martin A.
Pieters, Rob
den Boer, Monique L.
ONCOTARGET, 2017, 8 (52): : 89923 - 89938
[6] Mutations in TP53 Gene Is Independent Prognostic Factor for High Grade B-Cell Lymphoma
Misyurina, Anna Evgenevna
Misyurin, Vsevolod Andreevich
Misyurin, Andrey Vitalievich
Kovrigina, Alla Mikhailovna
Kravchenko, Sergey Kirillovich
Baryakh, Elena Alexandrovna
Magomedova, Aminat Umaraskhabovna
Pushkova, Elena Nikolaevna
Parovichnikova, Elena N.
Savchenko, Valery Grigorievich
BLOOD, 2016, 128 (22)
[7] Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype
Xu, Nan
Lai, Yue-Yun
Chen, Wen-Min
Jiang, Hao
Wang, Yu
Wang, Xu
Zhao, Xiao-Su
Huang, Xiao-Jun
Jiang, Qian
Qin, Ya-Zhen
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (05) : 892 - 899
[8] JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias
Kim, Sang-Kyu
Knight, Deborah A.
Jones, Lisa R.
Vervoort, Stephin
Ng, Ashley P.
Seymour, John F.
Bradner, James E.
Waibel, Michaela
Kats, Lev
Johnstone, Ricky W.
GENES & DEVELOPMENT, 2018, 32 (11-12) : 849 - 864
[9] TP53 Mutations in Hypodiploid Acute Lymphoblastic Leukemia
Comeaux, Evan Q.
Mullighan, Charles G.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (03):
[10] Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia
Malinge, Sebastien
Ben-Abdelali, Raouf
Settegrana, Catherine
Radford-Weiss, Isabelle
Debre, Marianne
Beldjord, Kheira
Macintyre, Elizabeth A.
Villeval, Jean-Luc
Vainchenker, William
Berger, Roland
Bernard, Olivier A.
Delabesse, Eric
Penard-Lacronique, Virginie
BLOOD, 2007, 109 (05) : 2202 - 2204

← 1 2 3 4 5 →